DWA
PLXP

Dorsey Wright & Associates’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Dorsey Wright & Associates’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,710
Closed -$91K – 348
2021
Q3 		$91K Buy
4,710
+368
+8% +$6.43K 0.02% 140
2021
Q2 		$60K Hold
4,342
– – 0.01% 163
2021
Q1 		$39.2K Buy
+4,342
New +$31.7K 0.46% 107

Other funds holding PLXP

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return

Dorsey Wright & Associates's PLXP Position: Q4 2021 in Review

Dorsey Wright & Associates sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2021, closing a stake of 4,710 shares — an estimated $91K sold.

Dorsey Wright & Associates first reported a position in PLXP in Q1 2021 and held it in 3 quarters. The position peaked at $91K in Q3 2021. 57 funds tracked by Wall St. Rank hold PLXP as of Q4 2021.

  • Dorsey Wright & Associates reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 4,710 PLx Pharma Inc. Common Stock shares in Q4 2021, an estimated $91K.
  • Dorsey Wright & Associates first reported a position in PLx Pharma Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Dorsey Wright & Associates's PLx Pharma Inc. Common Stock position peaked at $91K in Q3 2021.
  • 57 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2021.

Based on Dorsey Wright & Associates's 13F filing for Q4 2021, filed 27 Jan 2022.